Loading [MathJax]/jax/output/HTML-CSS/config.js
Login
Section Medicine

Serological Patterns of TORCH Infections in Early Pregnancy

Pola Serologis Infeksi TORCH pada Awal Kehamilan
Vol 10 No 1 (2025): June:

Alaa Mahdy Obaid Khzal (1)

(1) Department of Pathological Analyses, College of Science, University of Kufa, Najaf, Iraq
Fulltext View | Download

Abstract:

General Background: TORCH infections—comprising Toxoplasma gondii, Rubella virus, Cytomegalovirus (CMV), and Herpes simplex virus (HSV)—pose severe risks to fetal health if acquired during pregnancy, particularly in the first trimester. Specific Background: In Iraq, and specifically Najaf, epidemiological data on TORCH prevalence among pregnant women remains scarce, despite the known perinatal risks. Knowledge Gap: The absence of localized seroprevalence data and gestational-age-based immunological profiles limits the development of targeted maternal-fetal health strategies. Aim: This study aimed to assess TORCH infection rates, identify immunoglobulin patterns (IgM and IgG), and compare seropositivity across pregnancy trimesters in Najaf. Results: Among 100 participants, 62% tested positive for TORCH infections, with 58.1% of those in the first trimester showing acute infections, mainly due to T. gondii and HSV. Later trimesters showed chronic infections dominated by CMV and Rubella, evidenced by IgG presence. Novelty: This is the first study in Najaf to report trimester-specific TORCH immunological dynamics, revealing a distinct shift from acute to chronic infection profiles. Implications: These findings highlight the necessity for early TORCH screening and ongoing antenatal surveillance in Iraq to minimize congenital complications and inform public health interventions.
Highlight :




  • Early Detection Critical – Most acute infections (58.1%) occur in the first trimester, requiring urgent screening and intervention.




  • Pathogen Pattern Shifts – Toxoplasma and HSV dominate early infections, while CMV and Rubella persist chronically later.




  • Public Health Need – Routine TORCH testing and hygiene education must be integrated into antenatal care programs.




Keywords : TORCH Infections, Toxoplasma Gondii, Cytomegalovirus, Rubella Virus, Antenatal Screening


 

References

F. S. Nabiyeva and S. I. Umirkulova, “Diagnosis and Prevention of TORCH Infection in Pregnant Women,” Web of Medicine: Journal of Medicine, Practice and Nursing, vol. 3, no. 1, pp. 76–78, 2025.

X. Ren et al., “Serological Screening of TORCH Pathogen Infections in Infertile Women of Childbearing Age in Northwest China,” Reproductive Sciences, vol. 31, no. 9, pp. 2877–2884, 2024.

M. Naseem et al., “TORCH Pathogens-Induced Histopathological Changes in Placental Tissues and Associated Post Obstetric Complications,” Acta Tropica, vol. 261, 107466, 2025.

A. N. Fakhriddinovna, “The Impact of TORCH Infections on Pregnancy: Risks, Diagnosis and Prevention,” Shokh Library, pp. 521–529, 2024.

E. Hunsperger et al., “Seroconversion and Seroprevalence of TORCH Infections in a Pregnant Women Cohort Study, Mombasa, Kenya, 2017–2019,” Epidemiology and Infection, vol. 152, e68, 2024.

S. S. Firmino et al., “Toxoplasma Gondii Seropositivity and Co-Infection with TORCH Complex Pathogens in Pregnant Women from Araçatuba, Brazil,” Microorganisms, vol. 12, no. 9, 1844, 2024.

R. A. Shqara et al., “The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study,” Pediatric Infectious Disease Journal, vol. 43, no. 1, pp. 69–73, 2024.

G. Pavia et al., “Seroprevalence and Age-Related Susceptibility of TORCH Infections in Childbearing Age Women: A 5-Year Cross-Sectional Retrospective Study and a Literature Review,” Journal of Infection and Public Health, 2024, 102537.

A. Konopka et al., “A Comprehensive Review of TORCH Syndrome: Characterization and Prevention Strategies,” Quality in Sport, vol. 21, pp. 53987–53987, 2024.

M. K. Yarmuxamedova, “Prevalence and Analysis of TORCH Infections Among Women of Reproductive Age in the Samarkand Region,” Shokh Library, 2025.

E. P. Kahraman Kilbas et al., “Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis,” Pathogens, vol. 14, no. 1, 37, 2025.

S. Kirat, “Investigation of TORCH Seroprevalence in a Tertiary University Hospital,” Medicine Science, vol. 13, no. 4, 2024.

M. Naseem et al., “TORCH Pathogen-Induced Histopathological Changes in Placental Tissues and Associated Post Obstetric Complications in Pakistani Women,” 2024.

R. A. Shqara et al., “The Utility of Serologic TORCH Testing During Pregnancy for Maternal-Related Versus Fetal-Related Indications: A Retrospective Study,” Pediatric Infectious Disease Journal, vol. 44, no. 3, pp. 257–262, 2025.

S. Mansouri, Y. Alharbi, and A. Alqahtani, “Nanomaterials Connected to Bioreceptors to Introduce Efficient Biosensing Strategy for Diagnosis of the TORCH Infections: A Critical Review,” Critical Reviews in Analytical Chemistry, pp. 1–18, 2024.

S. F. Zimmerman, S. H. A. Bonon, and S. T. M. Marba, “Systematic Review on Molecular Detection of Congenital and Neonatal Infections Caused by TORCH and SARS-CoV-2 in Newborns' Cerebrospinal Fluid,” Revista Paulista de Pediatria, vol. 43, e2023191, 2024.

R. Karimah et al., “Successful Management of High-Risk Pregnancy with TORCH Infection History and Chronic Hypertension,” Journal of Medical and Health Technology, vol. 1, no. 2, pp. 6–14, 2024.

J. J. U. Cedeño et al., “Prevalencia, Complicaciones y Pruebas Diagnósticas por Sensibilidad y Especificidad del Perfil TORCH en Gestantes y Recién Nacidos,” Revista Científica Salud BIOSANA, vol. 4, no. 4, pp. 183–201, 2024.